Stryker entered into a definitive agreement to acquire instrument manufacturer Invuity for US $190MM in equity. The transaction is slated to close in 4Q18.
Paradigm Spine announced that BlueCross BlueShield of South Carolina issued a positive commercial payor policy covering coflex® to treat lumbar spinal stenosis.
Histogenics' Phase III clinical trial of NeoCart® tissue engineered implant did not meet the primary endpoint of a statistically significant improvement in pain and function vs. microfracture in a dual threshold responder analysis at one year.